A novel nucleoside analog, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro

Michael McDowell, Sarah R. Gonzales, Sidath C. Kumarapperuma, Marjan Jeselnik, Jeffrey B. Arterburn, Kathryn A. Hanley

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Antiviral therapies are urgently needed to control emerging flaviviruses such as dengue, West Nile, and yellow fever. Ribavirin (RBV) has shown activity against flaviviruses in cultured cells, but efficacy in animal models has generally been poor. In a preliminary screen of novel, synthetic 1-β-d-ribofuranosyl-azole analogs, two compounds, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR) and 1-β-d-ribofuranosyl-4-ethynyl-[1,3]imidazole (IM18), significantly reduced the replication of dengue virus serotype 2 (DENV-2) in cultured Vero cells. In the current study we demonstrated that the effective concentration 50 (EC50) of ETAR for DENV-2 is substantially lower than both IM18 and RBV. Moreover, ETAR reduced the replication of five additional flaviviruses, including DENV serotypes 1, 3 and 4, Langat virus and Modoc virus, ≥1000-fold relative to untreated controls. Addition of exogenous guanosine to DENV-2 infected cells negated the antiviral effects of both RBV and ETAR, indicating that GTP depletion is a major mechanism of action for both drugs. ETAR represents a promising drug candidate for the treatment of flavivirus infections.

Original languageEnglish (US)
Pages (from-to)78-80
Number of pages3
JournalAntiviral Research
Volume87
Issue number1
DOIs
StatePublished - Jul 2010

Bibliographical note

Funding Information:
Funding was provided by an NMSU Interdisciplinary Research grant and NIH NM-INBRE 2P20RR01648-09. SG was supported by the NMSU Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (MBRS-RISE) and National Institute of Health Grant ( GM61222 ). We thank Drs. Aravinda de Silva, Alexander Pletnev, Robert Tesh and Stephen Whitehead for providing viruses and other reagents.

Keywords

  • Antiviral
  • Dengue virus
  • ETAR
  • Flavivirus
  • Nucleoside analog
  • Ribavirin

Fingerprint Dive into the research topics of 'A novel nucleoside analog, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro'. Together they form a unique fingerprint.

Cite this